Gregory Cesarone

800 total citations
13 papers, 653 citations indexed

About

Gregory Cesarone is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Gregory Cesarone has authored 13 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Gregory Cesarone's work include Carbon Nanotubes in Composites (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and RNA Interference and Gene Delivery (2 papers). Gregory Cesarone is often cited by papers focused on Carbon Nanotubes in Composites (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and RNA Interference and Gene Delivery (2 papers). Gregory Cesarone collaborates with scholars based in United States, Spain and South Korea. Gregory Cesarone's co-authors include Heinz‐Josef Lenz, Robert D. Ladner, Jan Stoehlmacher, Mimi C. Yu, Susan Muller‐Weeks, Eric Wickstrom, Chang-Po Chen, Balaji Panchapakesan, Shaoxin Lu and Dmitry A. Goncharov and has published in prestigious journals such as Cancer Research, The FASEB Journal and Annals of Oncology.

In The Last Decade

Gregory Cesarone

13 papers receiving 646 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gregory Cesarone United States	9	304	260	142	88	74	13	653
Christiane Amendt Germany	12	440 1.4×	294 1.1×	102 0.7×	87 1.0×	47 0.6×	24	926
Seint T. Lwin United States	12	396 1.3×	411 1.6×	46 0.3×	55 0.6×	37 0.5×	19	898
Nadège Gaborit France	18	370 1.2×	449 1.7×	156 1.1×	63 0.7×	42 0.6×	24	773
Malika Trad France	10	148 0.5×	324 1.2×	50 0.4×	118 1.3×	80 1.1×	15	944
Fa Yang China	15	341 1.1×	210 0.8×	217 1.5×	43 0.5×	84 1.1×	34	748
Michiel Kroesen Netherlands	12	350 1.2×	464 1.8×	120 0.8×	51 0.6×	190 2.6×	21	1.2k
Yu Oyama Japan	15	106 0.3×	171 0.7×	106 0.7×	144 1.6×	29 0.4×	41	753
Chunyan Gu‐Trantien Belgium	16	234 0.8×	742 2.9×	136 1.0×	33 0.4×	49 0.7×	29	1.2k
Jim‐Ray Chen Taiwan	15	231 0.8×	182 0.7×	92 0.6×	50 0.6×	32 0.4×	34	566

Countries citing papers authored by Gregory Cesarone

Since Specialization

Citations

This map shows the geographic impact of Gregory Cesarone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Cesarone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Cesarone more than expected).

Fields of papers citing papers by Gregory Cesarone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Cesarone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Cesarone. The network helps show where Gregory Cesarone may publish in the future.

Co-authorship network of co-authors of Gregory Cesarone

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Cesarone. A scholar is included among the top collaborators of Gregory Cesarone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Cesarone. Gregory Cesarone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Currie, Jean-Christophe, et al.. (2023). Abstract 3942: Differential expression of a novel transport receptor, SORT1 (sortilin), in cancer versus healthy tissues that can be utilized for targeted delivery of anti-cancer drugs. Cancer Research. 83(7_Supplement). 3942–3942. 1 indexed citations

Chen, Hongli, et al.. (2023). Abstract 2763: Characterization of a novel immunohistochemistry (IHC) assay for CEACAM5 using a commercial antibody. Cancer Research. 83(7_Supplement). 2763–2763. 1 indexed citations

Scoazec, J-Y., Julien Adam, Philippe Rochaix, et al.. (2021). 1313P Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5) tumor expression in a phase I/II study of tusamitamab ravtansine (SAR408701) in patients (pts) with advanced non-small cell lung cancer (NSCLC). Annals of Oncology. 32. S1011–S1011. 1 indexed citations

Krymskaya, Vera P., Jennifer Snow, Gregory Cesarone, et al.. (2011). mTOR is required for pulmonary arterial vascular smooth muscle cell proliferation under chronic hypoxia. The FASEB Journal. 25(6). 1922–1933. 88 indexed citations

Aruva, Mohan R., Nylla Shanthly, C. Cardi, et al.. (2007). Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating peptide (PACAP) receptor specific peptide analogues for PET imaging of breast cancer: In vitro/in vivo evaluation. Regulatory Peptides. 144(1-3). 91–100. 33 indexed citations

Goncharova, Elena A., Dmitry A. Goncharov, Matthew Spaits, et al.. (2007). Interferon β Augments Tuberous Sclerosis Complex 2 (TSC2)-Dependent Inhibition of TSC2-Null ELT3 and Human Lymphangioleiomyomatosis-Derived Cell Proliferation. Molecular Pharmacology. 73(3). 778–788. 16 indexed citations

Cesarone, Gregory, et al.. (2007). Insulin Receptor Substrate 1 Knockdown in Human MCF7 ER+ Breast Cancer Cells by Nuclease-Resistant IRS1 siRNA Conjugated To a Disulfide-Bridged d-Peptide Analogue of Insulin-Like Growth Factor 1. Bioconjugate Chemistry. 18(6). 1831–1840. 61 indexed citations

Cesarone, Gregory, et al.. (2006). Detection of Live Breast Cancer Cells Using Carbon Nanotube Devices. TechConnect Briefs. 2(2006). 33–36. 1 indexed citations

Cesarone, Gregory, Cecilia Garofalo, Marc Abrams, et al.. (2006). RNAi‐mediated silencing of insulin receptor substrate 1 (IRS‐1) enhances tamoxifen‐induced cell death in MCF‐7 breast cancer cells. Journal of Cellular Biochemistry. 98(2). 440–450. 37 indexed citations

10.

Panchapakesan, Balaji, et al.. (2005). Single-Wall Carbon Nanotube Nanobomb Agents for Killing Breast Cancer Cells. 1(2). 133–140. 66 indexed citations

11.

Panchapakesan, Balaji, et al.. (2005). Single-Wall Carbon Nanotubes with Adsorbed Antibodies Detect Live Breast Cancer Cells. 1(4). 353–360. 14 indexed citations

12.

Boesze‐Battaglia, Kathleen, Andrew F.X. Goldberg, Janice H. Dispoto, et al.. (2003). A soluble peripherin/Rds C-terminal polypeptide promotes membrane fusion and changes conformation upon membrane association. Experimental Eye Research. 77(4). 505–514. 30 indexed citations

13.

Stoehlmacher, Jan, Susan Muller‐Weeks, Gregory Cesarone, et al.. (2003). A novel single nucleotide polymorphism within the 5' tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity.. PubMed. 63(11). 2898–904. 304 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact